Cardiopulmonary Exercise Testing Market Research Report Information by Product (CPET Metabolic Carts, and Software), by End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASE IN THE PREVALENCE OF CARDIOVASCULAR DISEASES

4.2.2 RISING GERIATRIC POPULATION

4.3 RESTRAINTS

4.3.1 LACK OF SKILLED AND EXPERIENCED PROFESSIONALS

4.4 OPPORTUNITIES

4.4.1 GROWING NUMBER OF STRATEGIC INITIATIVES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D & DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON KEY PLAYERS

5.3.3 IMPACT ON DEMAND

5.4 QUANTITATIVE MARKET INSIGHTS

5.4.1 NUMBER OF CPET METABOLIC CARTS BY REGION, 2022

5.4.2 AVERAGE TESTS PERFORMED IN 2022, BY TYPE OF FACILITIES, BY REGION, 2022

5.5 QUALITATIVE CONSUMER ASSESSMENT

5.5.1 DEMAND FOR CPET SOFTWARE IN MAJOR REGIONS

5.5.2 AVERAGE TIME REQUIRED FOR INTERPRETING CPET TESTS, INCLUDING REPORTING.

5.5.3 % CHANCES OF ADOPTION OF TECHNOLOGICAL ADVANCEMENTS SUCH AS SEMI-AUTOMATIC INTERPRETATION PROGRAM

5.5.4 RANGE OF % PROFITS BY FACILITIES PERFORMING CPET TESTS

5.5.5 % INVESTMENTS IN CPET SOFTWARE

6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 CPET METABOLIC CARTS

6.3 SOFTWARE

7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITALS & CLINICS

7.3 DIAGNOSTIC CENTERS

7.4 AMBULATORY CENTERS

7.5 OTHERS

8 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION

8.1 OVERVIEW

8.2 NORTH AMERICA

8.2.1 US

8.2.2 CANADA

8.3 EUROPE

8.3.1 GERMANY

8.3.2 FRANCE

8.3.3 UK

8.3.4 ITALY

8.3.5 SPAIN

8.3.6 REST OF EUROPE

8.4 ASIA-PACIFIC

8.4.1 CHINA

8.4.2 INDIA

8.4.3 JAPAN

8.4.4 AUSTRALIA

8.4.5 SOUTH KOREA

8.4.6 REST OF ASIA-PACIFIC

8.5 REST OF THE WORLD

8.5.1 MIDDLE EAST

8.5.2 AFRICA

8.5.3 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW

9.2 COMPETITIVE BENCHMARKING

9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

9.5 KEY DEVELOPMENT ANALYSIS

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.6.1 PRODUCT/COMPANY LAUNCH/PRODUCT APPROVAL

9.6.2 COLLABORATION/AGREEMENT

9.7 FINANCIAL MATRIX

9.7.1 SALES (USD MILLION), 2021

9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

10 COMPANY PROFILES

10.1 SCHILLER AG

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 COSMED SRL

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS OFFERED

10.2.4 KEY DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.2.6 KEY STRATEGIES

10.3 MGC DIAGNOSTICS CORPORATION

10.3.1 COMPANY OVERVIEWS

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 KEY STRATEGIES

10.4 OXIGRAF, INC

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 KEY STRATEGIES

10.5 VYAIRE MEDICAL, INC

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 KEY STRATEGIES

10.6 CORTEX BIOPHYSIK GMBH

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL OVERVIEW

10.6.3 PRODUCTS OFFERED

10.6.4 KEY DEVELOPMENTS

10.6.5 KEY STRATEGIES

10.7 KONINKLIJKE PHILIPS N.V.

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 SWOT ANALYSIS

10.7.6 KEY STRATEGIES

10.8 HILL-ROM HOLDINGS, INC

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS OFFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 KEY STRATEGIES

10.9 MEDEV MEDICAL DEVICES CORPORATION

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 SWOT ANALYSIS

10.9.6 KEY STRATEGIES

10.10 GERATHERM MEDICAL AG

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 SWOT ANALYSIS

10.10.6 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES

11.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 NUMBER OF CPET METABOLIC CARTS, BY REGION, 2022

TABLE 4 AVERAGE TESTS PERFORMED, BY REGION, 2022

TABLE 5 AVERAGE TIME REQUIRED FOR INTERPRETING CPET TESTS

TABLE 6 RANGE OF % PROFITS BY FACILITIES PERFORMING CPET TESTS

TABLE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 8 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, FOR CPET METABOLIC CARTS, BY REGION, 2019–2030 (USD MILLION)

TABLE 9 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, FOR SOFTWARE, BY REGION, 2019–2030 (USD MILLION)

TABLE 10 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END USER, 2019–2030 (USD MILLION)

TABLE 11 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019–2030 (USD MILLION)

TABLE 12 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, FOR DIAGNOSTIC CENTERS, BY REGION, 2019–2030 (USD MILLION)

TABLE 13 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, FOR AMBULATORY CENTERS, BY REGION, 2019–2030 (USD MILLION)

TABLE 14 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD MILLION)

TABLE 15 GLOBAL: CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION, 2019–2030 (USD MILLION)

TABLE 16 NORTH AMERICA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY, 2019–2030 (USD MILLION)

TABLE 17 NORTH AMERICA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 18 NORTH AMERICA: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 19 US: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 20 US: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 21 CANADA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 22 CANADA: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 23 EUROPE: CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY, 2019–2030 (USD MILLION)

TABLE 24 EUROPE: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 25 EUROPE: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 26 GERMANY: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 27 GERMANY: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 28 FRANCE: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 29 FRANCE: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 30 UK: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 31 UK: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 32 ITALY: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 33 ITALY: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 34 SPAIN: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 35 SPAIN: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 36 REST OF EUROPE: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 37 REST OF EUROPE: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 38 ASIA-PACIFIC: CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY, 2019–2030 (USD MILLION)

TABLE 39 ASIA-PACIFIC: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 40 ASIA-PACIFIC: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 41 CHINA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 42 CHINA: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 43 INDIA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 44 INDIA: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 45 JAPAN: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 46 JAPAN: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 47 AUSTRALIA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 48 AUSTRALIA: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 49 SOUTH KOREA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 50 SOUTH KOREA: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 51 REST OF ASIA-PACIFIC: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 52 REST OF ASIA-PACIFIC: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 53 REST OT THE WORLD: CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION, 2019–2030 (USD MILLION)

TABLE 54 REST OT THE WORLD: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 55 REST OT THE WORLD: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 56 MIDDLE EAST: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 57 MIDDLE EAST: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 58 AFRICA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 59 AFRICA: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 60 LATIN AMERICA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 61 LATIN AMERICA: CARDIOPULMONARY EXERCISE TESTING MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 62 MAJOR PLAYERS IN THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

TABLE 63 MOST ACTIVE PLAYER IN THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

TABLE 64 PRODUCT/COMPANY LAUNCH/PRODUCT APPROVAL

TABLE 65 COLLABORATION/AGREEMENT

TABLE 66 SCHILLER AG: PRODUCTS OFFERED

TABLE 67 COSMED SRL: PRODUCTS OFFERED

TABLE 68 COSMED SRL: KEY DEVELOPMENTS

TABLE 69 MGC DIAGNOSTICS CORPORATION: PRODUCTS OFFERED

TABLE 70 MGC DIAGNOSTICS CORPORATION: KEY DEVELOPMENTS

TABLE 71 OXIGRAF, INC: PRODUCTS OFFERED

TABLE 72 VYAIRE MEDICAL, INC: PRODUCTS OFFERED

TABLE 73 CORTEX BIOPHYSICS GMBH: PRODUCTS OFFERED

TABLE 74 KONINKLIJKE PHILIPS NV: PRODUCTS OFFERED

TABLE 75 HILL-ROM HOLDINGS, INC: PRODUCTS OFFERED

TABLE 76 MEDEV MEDICAL DEVICES CORPORATION: PRODUCTS OFFERED

TABLE 77 GERATHERM MEDICAL AG: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 9 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2019-2030 (USD MILLION)

FIGURE 10 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT, 2022 & 2030 (USD MILLION)

FIGURE 11 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET SHARE (%), BY PRODUCT, 2022

FIGURE 12 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2030 (USD MILLION)

FIGURE 13 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END USER, 2022 & 2030 (USD MILLION)

FIGURE 14 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET SHARE (%), BY END USER, 2022

FIGURE 15 GLOBAL: CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION, 2022 & 2030 (USD MILLION)

FIGURE 16 GLOBAL: CARDIOPULMONARY EXERCISE TESTING MARKET SHARE (%), BY REGION, 2022

FIGURE 17 NORTH AMERICA MARKET ANALYSIS: CARDIOPULMONARY EXERCISE TESTING MARKET, 2019-2030 (USD MILLION)

FIGURE 18 NORTH AMERICA: CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)

FIGURE 19 NORTH AMERICA: CARDIOPULMONARY EXERCISE TESTING MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 20 EUROPE MARKET ANALYSIS: CARDIOPULMONARY EXERCISE TESTING MARKET, 2019-2030 (USD MILLION)

FIGURE 21 EUROPE: CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)

FIGURE 22 EUROPE: CARDIOPULMONARY EXERCISE TESTING MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 23 NUMBER OF PEOPLE AGED 60 YEARS OR OVER IN ASIA-PACIFIC, BY SUB-REGIONS, 2022, 2030 AND 2050 (IN MILLIONS)

FIGURE 24 ASIA-PACIFIC MARKET ANALYSIS: CARDIOPULMONARY EXERCISE TESTING MARKET, 2019-2030 (USD MILLION)

FIGURE 25 ASIA-PACIFIC: CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)

FIGURE 26 ASIA-PACIFIC: CARDIOPULMONARY EXERCISE TESTING MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 27 REST OF THE WORLD MARKET ANALYSIS: CARDIOPULMONARY EXERCISE TESTING MARKET, 2019-2030 (USD MILLION)

FIGURE 28 REST OT THE WORLD: CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION, 2022 & 2030 (USD MILLION)

FIGURE 29 REST OT THE WORLD: CARDIOPULMONARY EXERCISE TESTING MARKET SHARE (%), BY REGION, 2022

FIGURE 30 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 31 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 32 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: COMPETITIVE LANDSCAPE

FIGURE 33 SALES 2021

FIGURE 34 RESEARCH & DEVELOPMENT EXPENDITURE, 2021

FIGURE 35 SCHILLER AG: SWOT ANALYSIS

FIGURE 36 COSMED SRL: SWOT ANALYSIS

FIGURE 37 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS

FIGURE 39 MEDEV MEDICAL DEVICES CORPORATION: SWOT ANALYSIS

FIGURE 40 GERATHERM MEDICAL AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 GERATHERM MEDICAL AG: SWOT ANALYSIS